NovaBiotics Receives Most Innovative EU Biotech SME 2017 Award

Category: Press Releases

Award Close Up Nova Biotics Winners

NovaBiotics, the clinical-stage anti-infectives biotechnology company, was named Most Innovative EU Biotech SME at EuropaBio’s 8th annual SME Awards in Brussels, recognising the Company's innovation in tackling Antimicrobial Resistance (AMR) as one of our greatest global health challenges. Europabio Press Release

The EuropaBio Awards celebrate highly innovative small and medium sized enterprises from across Europe that have developed novel ways of meeting societal, technical, and environmental problems through the application of biotech. The panel who selected NovaBiotics as the winner of the ‘Red biotech’ award comprised biotech experts and leaders who understand the science, funding realities and broader European biotech ecosystem in which SMEs operate.

NovaBiotics is a leading innovator in the anti-infectives space and have gone back to the drawing board to develop a novel approach to antibacterial and antifungal drug design using ‘smart immunology’ and biology-led intelligent drug design. Its technology and business model has been validated through successful development, from concept to clinic, of two lead products and securing the most appropriate commercial collaborations to enable the delivery of these highly promising therapy candidates to markets of significant worth.

Dr Deborah O’Neil, Chief Executive Officer, said “We are thrilled to have been named as the Most Innovative EU Biotech at Wednesday night’s ceremony in Brussels in the Red Biotech (Healthcare) category. Being awarded such a prestigious, Europe wide award and in such an impressively strong field is fantastic recognition of our leading innovation in AMR and anti-infectives drug discovery. My sincere thanks go out to the prestigious panel of judges who made the decision based on our innovation and contribution to the global AMR crisis. I am also extremely proud that we accepted this award from the largest and most influential biotech industry group on the continent.”